Glenmede Trust CO Na Bridge Bio Pharma, Inc. Transaction History
Glenmede Trust CO Na
- $20.6 Billion
- Q3 2024
A detailed history of Glenmede Trust CO Na transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Glenmede Trust CO Na holds 16,315 shares of BBIO stock, worth $386,991. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,315
Previous 16,128
1.16%
Holding current value
$386,991
Previous $408,000
1.72%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding BBIO
# of Institutions
291Shares Held
171MCall Options Held
10.4MPut Options Held
2.37M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$599 Million35.94% of portfolio
-
Viking Global Investors LP25.1MShares$596 Million2.47% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$337 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$295 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$144 Million63.58% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $3.52B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...